Cesca Therapeutics Inc. (KOOL) announced the restructuring of its sales, marketing and technical support organization and the appointment of Tim Lee as Director of International Sales. In the newly formed role, Lee's primary focus will be to lead global cord blood product sales and services. As Cesca's clinical programs reach therapeutic market commercialization, Lee will work directly with the company's President, Ken Harris, to develop and implement the sales and marketing resources to commercialize and scale these programs, the company said.
The restructuring will realign Hal Baker from his current role as Vice President of Commercial Operations, to an external consulting and advisory role, which will ensure an orderly and seamless transition of his existing responsibilities with specific attention given to cord blood sales and marketing initiatives.
The company said its restructuring is aimed at further strengthening its cord blood business and new point of care and clinical commercial programs by providing more dedicated resource leadership to each discipline.
For comments and feedback contact: editorial@rttnews.com
Business News